Use of a panel of markers in the differential diagnosis of adenocarcinoma and reactive mesothelial cells in fluid cytology

American Journal of Clinical Pathology

Volumn 116, Issue 5, 2001, Pages 709-715

  Ko, Ellen C ^a   Jhala, Nirag C ^a   Shultz, Jana J ^a   Chhieng, David C ^a  

^a Dept of Pathology ^*  (United States)

Author keywords

Adenocarcinoma; B72.3; Calretinin; Carcinoembryonic antigen; Cytology; Immunocytochemistry; Mesothelial cells; Mucicarmine; Serous effusion

Indexed keywords

B72 3 ANTIGEN; CALRETININ; CARCINOEMBRYONIC ANTIBODY; CARCINOEMBRYONIC ANTIGEN; DYE; MUCICARMINE; PROTEIN ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; BENIGN TUMOR; CANCER CYTODIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EFFUSION; EPITHELIUM CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MESOTHELIUM CELL; METASTASIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; ANTIBODIES, NEOPLASM; ASCITIC FLUID; CARCINOEMBRYONIC ANTIGEN; CARMINE; CELL COUNT; COLORING AGENTS; DIAGNOSIS, DIFFERENTIAL; EPITHELIUM; FEMALE; HUMANS; PERICARDIAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0035736057     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/PJ7H-A52V-M3XB-V94Y     Document Type: Article

References (49)

1. The results of some cytochemical reactions in metastatic malignant tumor cells in pleural and peritoneal effusions
2. Transmission and scanning electron microscopic studies of cells in effusions
3. Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies
4. Backscatter electron imaging of cells from effusions
5. Cytogenetic diagnosis of cancer from body fluids
6. Keratins of different molecular weight in exfoliated mesothelial and adenocarcinoma cells: An aid to cell identification
7. Analysis of pleural effusions using automated flow cytometry
8. Configuration of surfaces of human cancer cells in effusions: A review
9. Immunocytochemical profile of benign and carcinomatous effusions: A practical approach to difficult diagnosis
10. The distinction of adenocarcinoma from malignant mesothelioma in cell blocks of effusions: The role of routine mucin histochemistry and immunohistochemical assessment of carcinoembryonic antigen, keratin proteins, epithelial membrane antigen, and milk fat globule-derived antigen
11. Value of immunocytochemistry in the study of malignant effusions
12. The use of immunoperoxidase panels for the cytologic diagnosis of malignancy in serous effusions
13. Immunocytochemical panel for the identification of malignant cells in serous effusions
14. Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma
15. Frequent expression of the tumor antigen CAK1 in squamous-cell carcinomas
16. Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma
17. Cytologic diagnosis of malignant mesothelioma in serous effusions using an antimesothelial-cell antibody
18. Utility of the antibodies CA 19-9, HBME-1, and thrombomodulin in the diagnosis of malignant mesothelioma and adenocarcinoma in cytology
19. ME1-antibody labelling of primary bronchogenic tumours and extrapulmonary malignancies
20. Parathyroid hormone-related protein antigen localization distinguishes between mesothelioma and adenocarcinoma of the lung
21. Calretinin: A gene for a novel calcium-binding protein expressed principally in neurons
22. Calretinin: A novel immunocytochemical marker for mesothelioma
23. The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type
24. The immunohistochemical diagnostic panel for epithelial mesothelioma: A reevaluation after heat-induced epitope retrieval
25. E-cadherin and calretinin: A useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma
26. Calretinin: A selective marker of normal and neoplastic mesothelial cells in serous effusions
27. Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions
28. Occurrence of intercellular spaces (windows) in metastatic adenocarcinoma in serous fluids: A cytomorphologic, histochemical, and ultrastructural study
29. Electron microscopy in the diagnosis of pleural mesotheliomas
30. Malignant mesothelioma: Ultrastructural distinction from adenocarcinoma
31. Diffuse epithelial mesothelioma: A review of the ultrastructural spectrum
32. Histological staining for the diagnosis of mesothelioma
33. Histochemistry in the diagnosis of malignant mesothelioma
34. Mucin-positive epithelial mesotheliomas: A histochemical, immunohistochemical, and ultrastructural comparison with mucin-producing pulmonary adenocarcinomas
35. Pathology of human mesothelioma: Etiologic and diagnostic considerations
36. The pleura
37. Immunohistochemical properties of malignant mesothelioma cells in histologic and cytologic specimens
38. Differential diagnosis between mesothelioma and adenocarcinoma: A multimodal approach based on ultrastructure and immunocytochemistry
39. Immunocytochemistry in the differential diagnosis of effusions: Use of logistic regression to select a panel of antibodies to distinguish adenocarcinomas from mesothelial proliferations
40. Markers for metastatic adenocarcinoma in serous effusion specimens
41. Distinction between carcinoma cells and mesothelial cells in serous effusions: Usefulness of immunohistochemistry
42. Use of a monoclonal antibody (B72.3) as a novel immunohistochemical adjunct for the diagnosis of carcinomas in fine needle aspiration biopsy specimens
43. Identification of adenocarcinoma in Cytospin preparations of effusions using monoclonal antibody B72.3
44. Distinction of mesothelioma from carcinoma in pleural effusions: An immunocytochemical study on routinely processed cytoblock preparations
45. Tuberculous pleural effusions: Lymphocyte phenotypes in comparison with other lymphocyte-rich effusions
46. The immunohistochemical diagnosis of mesothelioma: Differentiation of mesothelioma and lung adenocarcinoma
47. E-cadherin, N-cadherin, and calretinin in pleural effusions: The good, the bad, the worthless
48. Calcium-binding proteins: Selective markers of nerve cells
49. Intracellular calcium homeostasis